Natives Engaged in Alzheimers Research - 'Ike Kupuna

NCT05534607 | Recruiting DMC

• 1 other identifier: 'Ike Kupuna
• Study Type: interventional
• Target: 192
• Locations: 1 country
• Sites: 3

Brief Summary

This study will conduct a group randomized trial to test the effects of a hula-based intervention in improving vascular risk factors for ADRD and cognitive complaints and function over 12 months.

Conditions

Mild Cognitive Impairment; Subjective Cognitive Impairment

Keywords

MCI; Alzheimer's disease; Alzheimer's disease and related dementias; Vascular dementia; ADRD; SCI; Native Hawaiian and Pacific Islander; NHPI; Hula; cultural based intervention; behavioral intervention

Outcome Measures

Primary Outcomes (8)

• Change in participants' systolic blood pressure at each time frame from baseline

  Vascular risk factor assessed using Omron©HEM-907XL

  3 months, 8 months, 12 months

• Change in participants' Hemoglobin A1c at each time frame from baseline

  Vascular risk factor assessed using Alere Cholestech LDX® System

  12 months

• Change in participants' total cholesterol at each time frame from baseline

  Vascular risk factor assessed using Alere Cholestech LDX® System

  3 months, 8 months, 12 months

• Change in participants' body mass index at each time frame from baseline

  Vascular risk factor assessed using Tanita BWB800AS scale

  3 months, 8 months, 12 months

• Change in participants' Cognitive Change Index score at each time frame from baseline

  Cognitive function assessed using Cognitive Change Index assessment

  3 months, 8 months, 12 months

• Change in participants' Number Symbol Coding Test score at each time frame from baseline

  Cognitive function assessed using Number Symbol Coding Test

  3 months, 8 months, 12 months

• Change in participants' overall Cognivue score at each time frame from baseline

  Cognitive function assessed using Cognivue device

  3 months, 8 months, 12 months

• Change in participants' overall Quick Dementia Rating System score at each time frame from baseline

  Cognitive function assessed using Quick Dementia Rating System assessment

  3 months, 8 months, 12 months

Study Arms (2)

Intervention group

EXPERIMENTAL

The intervention group will immediately receive the Ola Mau i ka Hula intervention after randomization for 12 months. The intervention program is 8 months with a 4 month self-monitoring period.

Behavioral: Ola Mau i ka Hula

Wait-list control group

NO INTERVENTION

After baseline data collection, participants randomized to the wait-list control arm will not receive the Ola Mau i ka Hula Program while their counterparts who were randomized to the intervention arm are undergoing the intervention program. Thus, they will not be offered the intervention until after the intervention arm is completed and their 12-month follow-up data collection is completed. They will only receive the educational component of the intervention from us during this 12-month period but they will be instructed to continue with their routine medical care as usual. Wait-list control group will be offered the opportunity to receive intervention at the conclusion of 12 month assessment period, regardless of whether they were retained for the full 12 months of data collection.

Interventions

Ola Mau i ka Hula BEHAVIORAL

The first 3 months of the hula-based intervention program was designed and standardized as a culturally-based physical activity (PA) that includes 15 minutes of ADRD education and intervention orientation with 12 weeks of hula lessons. These hula lessons consist of two 60-minute classes per week over 12 weeks. Each hula lesson will consist of 8 participants, providing them with the opportunity to engage-in this social support network. For the remaining 5 months of the Ola Mau i ka Hula Program, hula lessons led by the kumu hula will be reduced to once a month for 60 min. In addition, the intervention group will meet with a community-peer educator weekly over this 5-month period. Each meeting will be 90 minutes in length with 60 minutes of hula practice following the same format as previous classes, and 30 minutes will cover the PILI Lifestyle Plan curriculum and cultural-based cognitive exercises, alternating weekly.

Also known as: Ola Mau

Intervention group

Eligibility Criteria

• Age: 50 Years - 75 Years
• Sex: all
• Healthy Volunteers: Yes
• Age Groups: Adult (18-64), Older Adult (65+)

You may qualify if:

• self-reported Native Hawaiian or other Pacific Islander ancestry;
• ages 50+ but not older than 75 (optimal age range for preventing future dementia in people with cognitive impairment, above 75 is not likely to benefit from this study given their advance age);
• has subjective cognitive impairment (SCI) or mild cognitive impairment (MCI);
• have a diagnosis of hypertension, diabetes, dyslipidemia, or obesity (body-mass-index ≥ 30 kg/m2);
• physically able and willing to engage in moderate physical activity necessary for Hula; and
• physician's approval to participate in moderate physical activity

You may not qualify if:

• currently pregnant;
• already actively practicing Hula at least once per week; or
• clinical diagnosis of ADRD (mild to severe); or
• current diagnosed major depressive disorder at moderate or greater stage, or moderate or greater depression on the Center for Epidemiological Studies Depression Scale (CES-D).

Sponsors & Collaborators

• University of Hawaii: lead

Study Sites (3)

Kula No Na Po'e

Honolulu, Hawaii, 96813, United States

RECRUITING

Kokua Kalihi Valley

Honolulu, Hawaii, 96819, United States

RECRUITING

Hui No Ke Ola Pono

Wailuku, Hawaii, 96793, United States

RECRUITING

MeSH Terms

Conditions

Cognitive Dysfunction; Alzheimer Disease; Dementia, Vascular

Condition Hierarchy (Ancestors)

Cognition Disorders; Neurocognitive Disorders; Mental Disorders; Dementia; Brain Diseases; Central Nervous System Diseases; Nervous System Diseases; Tauopathies; Neurodegenerative Diseases; Cerebrovascular Disorders; Intracranial Arteriosclerosis; Intracranial Arterial Diseases; Leukoencephalopathies; Arteriosclerosis; Arterial Occlusive Diseases; Vascular Diseases; Cardiovascular Diseases

Study Officials

• Joseph K Kaholokula, PhD

  University of Hawaii

  PRINCIPAL INVESTIGATOR

Central Study Contacts

Janice K Worthington, MPH

CONTACT

8086921023; ikekupuna@gmail.com

Study Design

• Study Type: interventional
• Phase: not applicable
• Allocation: RANDOMIZED
• Masking: NONE
• Purpose: PREVENTION
• Intervention Model: PARALLEL
• Sponsor Type: OTHER
• Responsible Party: SPONSOR

Model Details: The study uses a wait list control design, where the wait-list control group is offered the intervention at the completion of the intervention group's 12-month intervention and assessment period.

Study Record Dates

• First Submitted: August 12, 2022
• First Posted: September 9, 2022
• Study Start: September 15, 2022
• Primary Completion: June 15, 2025
• Study Completion (Estimated): April 30, 2027
• Last Updated: August 1, 2024

Record last verified: 2024-07

Locations

US (3)